A cross-sectional, population-based, 2-stage prevalence study was conducted in a sample of 1019 community-dwelling persons over the age of 70 years living in Istanbul. In the first phase, participants were screened with the Mini-Mental State Examination for evidence of cognitive impairment. In the second phase, 79% of those who screened positive (n = 322) and 9% of screen-negatives (n = 63) underwent a standardized diagnostic workup. Diagnosis of dementia and Alzheimer's disease (AD) was made according to established criteria. Ninety-three cases of dementia were identified, 58 of whom were diagnosed with probable AD. Based on these numbers, the prevalence rates of probable AD and dementia were calculated to be 11.0% (95% CI, 7.0% to 15.0%) and 20.0% (95% CI, 14.0% to 26.0%), respectively, in this population. Prevalence rates of dementia and AD in Istanbul, Turkey, are comparable with those seen in the Western world.
Rocca WA, Hofman A., Brayne C., et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol. 1991;30:381-390.
2.
Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA.1989;262:2551-2556.
3.
Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA.1995;273:1354-1359.
4.
Canadian Study of Health and Aging Working Group.Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J.1994;150:899-913.
5.
Fukunishi I. , Hayabara T., Hosokawa K.Epidemiological surveys of senile dementia in Japan. Int J Soc Psychiatry. 1991;37:51-56.
6.
Ferri CP, Prince M., Brayne C., et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112-2117.
7.
Prince MJThe need for research on dementia in developing countries. Trop Med Health. 1997;2:993-1000.
8.
Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res. 1983;17:37-49.
9.
Harmanci H., Emre M., Gürvit H., et al. Risk factors for Alzheimer disease: a population-based case—control study in Istanbul, Turkey. Alzheimer Dis Assoc Disord. 2003;17:139-145.
10.
Şahin HA, Gürvit H., Emre M., et al. The attitude of elderly lay people towards the symptoms of dementia. Int Psychogeriatr. 2006;18:251-258.
11.
Kulaksizoglu, IB, Gürvit H., Polat A., et al. Unrecognized depression in community-dwelling elderly persons in Istanbul. Int Psychogeriatr. 2004;16:4-10.
12.
Yokeş MB, Emre M., Harmanci H., et al. The apolipoprotein E (APOE) genotype in a Turkish population with Alzheimer's disease. BalkanJ Med Genet.2005;8:57-63.
13.
Gungen C., Ertan T., Eker E., et al. The standardized Mini-Mental State Examination in Turkish. Paper presented at: 9th Congress of International Psychogeriatric Association; August 15-20, 1999; Vancouver, Canada.
14.
Folstein M. , Folstein S., McHugh PRMini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
15.
Ertan T., Eker E., Gungen C., et al. The Standardized Mini-Mental State Examination for illiterate Turkish elderly population. Paper presented at: 2nd International Symposium on Neurophysiological and Neuropsychological Assessment of Mental and Behavioral Disorders; August 28-30, 1999; Kirazliyayla, Bursa, Turkey.
16.
Katzman R., Brown T., Fuld P., Peck A., Schechter R., Schimmel H.Validation of the short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734-739.
17.
Blessed G., Tomlinson B., Roth M.The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Brit J Psychiatry . 1968;114:797-811.
18.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
19.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EMClinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
20.
Roman GC, Tatemichi TK, Erkinjuntti T., et al. Vascular dementia; diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology . 1993;43:250-260.
21.
McKeith IG, Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology. 1996;47:1113-1124.
22.
Neary D., Snowden JS, Gustafson L., et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
Morris J.The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
25.
Reisberg B. , Ferris S., de Leon M., Crook T.The global deterioration scale for the assessment of primary progressive dementia. Am J Psychiatry. 1982;139:1136-1139.
26.
Kawas CH, Katzman R.Epidemiology of dementia and Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, Sisodia SS, eds. Alzheimer Disease. Philadelphia, PA: Lippincott Williams and Wilkins;1999:95-116.
27.
Bohnstedt M. , Fox PJ, Kohatsu NDCorrelates of Mini-Mental Status Examination scores among elderly demented patients: the influence of race-ethnicity. J Clin Epidemiol. 1994;47:1381-1387.
28.
Ford GR, Haley WE, Thrower SL, West CA, Harrell LEUtility of Mini-Mental State Exam scores in predicting functional impairment among white and African American dementia patients. J Gerontol A Biol Sci Med Sci. 1996;51:M185-M188.
29.
Espino DV, Lichtenstein MJ, Palmer RF, Hazuda HPEthnic differences in mini-mental state examination (MMSE) scores: where you live makes a difference. J Am Geriatr Soc. 2001;49:538-548.
30.
Wood RY, Giuliano KK, Bignell CU, Pritham WWAssessing cognitive ability in research: use of MMSE with minority populations and elderly adults with low education levels. J Gerontol Nurs.2006;32:45-54.
31.
Vas CJ, Pinto C., Panikker D., et al. Prevalence of dementia in an urban Indian population. Int Psychogeriatr. 2001;13:439-450.
32.
Lin RT, Lai CL, Tai CT, Liu CK, Yen YY, Howng SLPrevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci. 1998;160:67-75.
33.
Zhang ZX, Zahner GE, Román GC, et al. Dementia subtypes in China. Prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol.2005;62:447-453.
34.
Andersen K. , Lolk A., Nielsen H., Andersen J., Olsen C., Kragh-Sorensen P.Prevalence of very mild to severe dementia in Denmark. Acta Neurol Scand. 1997; 96:82-87.
35.
Bilgiç B.Gürvit H., HanağasI H., et al. Erken evre Alzheimer hastalIğI ve demanssIz kognitif bozukluk tanIlI hastalarIn klinik ve laboratuar parametrelerinin karşIlatşrIlmasI . Paper presented at: 38th Turkish National Congress of Neurology; October 2002; Antalya. Turkish J Neurol. (special edition) 2002:41. Abstract.
36.
Jorm AF, Korten AE, Henderson ASThe prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76:465-479.
37.
Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B.Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm . Neurology. 1997;48:132-138.
38.
Brayne C., Gill C., Huppert FA, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life. Br J Psychiatry. 1995;167:255-262.
39.
Yoshitake T. , Kiyohara Y., Kato I., et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45:1161-1168.
40.
Paykel ES, Brayne C., Huppert FA, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry. 1994 ;51:325-332.
41.
Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993;43:515-519.
42.
Andersen K. , Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. Neurology . 1999;53:1992-1997.
43.
Blansjaar BA, Thomassen R., Van Schaick HWPrevalence of dementia in centenarians. Int J Geriatr Psychiatry . 2000;15:219-225.
44.
Ritchie K., Kildea D.Is senile dementia “age-related” or “ageing-related?”—evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995;346: 931-934.
45.
Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo JM, Dartiques JFAre sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry. 1999;66:177-183.
46.
Evans DA, Hebert LE, Beckett LA, et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol.1997;54:1399-1405.
47.
Qiu C., Bäckman L., Winblad B., Aquero-Torres H., Frataglioni L.The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol. 2001;58:2034-2039.
48.
Ott A., Breteler MM, van Harskamp F., Stijnen T., Hofman A.Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310:970-973.
49.
Letenneur L. , Launer LJ, Andersen K., et al. Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. Am J Epidemiol. 2000;151:1064-1071.
50.
Cobb JL, Wolf PA, Au R., White R., D'Agostino RBThe effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology. 1995;45:1707-1712.
51.
Sklavounou E., Economou-Petersen E., Karadima G., et al. Apolipoprotein E polymorphism in the Greek population. Clin Genet.1997;52:216-218.
